Sidley has built a reputation for being a powerful legal adviser for global businesses. With more than 2,000 lawyers across 20 offices worldwide, Sidley maintains a commitment to providing quality legal services and to offering advice in litigation, transactional and regulatory matters spanning virtually every area of law.
Sidley’s Boston office—located in a key hub for biopharmaceutical and medtech innovation—serves as an important role in our commitment to serve clients in key business hubs around the world. Harnessing the firm’s global reach, our lawyers collaborate across multiple legal disciplines to help clients achieve their business objectives.
Our Global Life Sciences Practice
Sidley’s pioneering Global Life Sciences practice comprises an experienced team of approximately 200 lawyers across numerous legal disciplines and three continents. Many of our colleagues spent time in senior roles in government, providing key insight into how key regulators work. We understand the challenges life sciences organizations face in the course of conducting business—whether they are start-ups bringing new products to market or navigating the global drug and device supply chain, having counseled high-profile clients in every sector of the dynamic life sciences industry.
Advising on the full scope of regulatory, compliance and enforcement, litigation and transactional matters, we offer a holistic legal approach that will smooth the path for life sciences organizations to navigate industry changes, technological advances, market demands and policy hurdles.
Recent recognition includes:
- Law360 “Practice Group of the Year” 2019 – Life Sciences
- U.S. News – Best Lawyers “Best Law Firms” 2020, FDA Law
Our COVID-19 Resource Center and Regulatory Development Updates
Sidley has a multidisciplinary task force dedicated to addressing the wide range of regulatory, transactional, and litigation issues companies face in responding to the coronavirus outbreak. Please click here for our latest updates, insights, podcasts, and webinars.
Sidley’s Food, Drug and Medical Device Regulatory group closely monitors rapidly evolving regulatory developments for COVID-19 globally. Click here for key highlights, and links to relevant material.
Sep 20, 2021
Posted by Sidley Austin